Â
Sponsored by
HEALTH NEWS
FDA revokes approval of Avastin for breast cancer
Posted: Nov 18, 2011 8:33 AM by Associated Press (AW)
WASHINGTON (AP) - The Food and Drug Administration has declared the blockbuster drug Avastin should no longer be used in breast cancer patients because there's no proof it extends their lives - and it is causing dangerous side effects.
Friday's ruling was long expected, but is sure to disappoint women who say they've run out of other options.
FDA Commissioner Dr. Margaret Hamburg called the decision
difficult but said patients must have confidence that drugs sold for their condition are effective.
Avastin won't stop selling, as it's also used to treat colon cancer and certain other tumors, but the FDA ruling is expected to influence insurance coverage. Medicare says it will continue to cover Avastin while it evaluates whether a change is needed.
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at feedback@ksby.com, and include the name of the story and information on the comment.
Thank you! KSBY.com
KSBY.com is social!
KSBY.COM VIDEOS
-
Military widow finds another woman's name engraved on her husband's tombstone
Views: 271 June 18, 2013 -
Mother taken into custody after driving under the influence with her son in the car
Views: 43 June 18, 2013 -
Middle schoolers get opportunity to play paintball with local law enforcement
Views: 12 June 16, 2013
Comments